Hirtle Callaghan & Co’s Alerian MLP ETF AMLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,541
Closed -$143K 150
2017
Q3
$143K Buy
2,541
+18
+0.7% +$1.03K 0.01% 84
2017
Q2
$150K Hold
2,523
0.02% 26
2017
Q1
$160K Sell
2,523
-4,200
-62% -$270K 0.03% 25
2016
Q4
$423K Sell
6,723
-24
-0.4% -$1.48K 0.07% 15
2016
Q3
$428K Sell
6,747
-31
-0.5% -$1.96K 0.09% 60
2016
Q2
$431K Buy
6,778
+472
+7% +$28.4K 0.08% 56
2016
Q1
$344K Buy
6,306
+1,027
+19% +$52.2K 0.06% 64
2015
Q4
$317K Buy
+5,279
New +$330K 0.07% 28

Other funds holding AMLP

Hirtle Callaghan & Co's AMLP Position: Q4 2017 in Review

Hirtle Callaghan & Co sold out of Alerian MLP ETF (AMLP) in Q4 2017, closing a stake of 2,541 shares — an estimated $143K sold.

Hirtle Callaghan & Co first reported a position in AMLP in Q4 2015 and held it in 8 quarters. The position peaked at $431K in Q2 2016. 618 funds tracked by Wall St. Rank hold AMLP as of Q4 2017.

  • Hirtle Callaghan & Co reported no remaining Alerian MLP ETF position as of Q4 2017 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 2,541 Alerian MLP ETF shares in Q4 2017, an estimated $143K.
  • Hirtle Callaghan & Co first reported a position in Alerian MLP ETF in Q4 2015 and held it in 8 quarters.
  • Hirtle Callaghan & Co's Alerian MLP ETF position peaked at $431K in Q2 2016.
  • 618 funds tracked by Wall St. Rank held Alerian MLP ETF as of Q4 2017.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2017, filed 17 Jan 2018.